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Aims: The aimof this study is to investigate the effect of hemin in colonic epithelial cells (Caco-2) cell proliferation
and if this effect was due to a direct modulation of 18-kDa translocator protein (TSPO) and/or heme oxygenase
type 1 (HO-1).
Main methods: The main methods are as follow: cell proliferation and cell cytotoxic assays on Caco-2 cell lines
treated with hemin in the presence or not of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-
isoquinolinecarboxamide (PK 11195) and Sn-protoporphyrin IX (Sn-PPIX), and immunoblotting for TSPO and
HO-1 protein analysis, siRNA directed against TSPO.
Key ﬁndings:Heminwas shown to be toxic for the Caco-2 cell line in a concentration and time dependentmanner.
Although hemin was able to induce HO-1 in a dose dependent manner, a speciﬁc HO-1 inhibitor, Sn-PPIX, was
unable to interfere with the effect of hemin on Caco-2 cells. Instead, PK 11195, a speciﬁc TSPO ligand, was able
to counteract the effect of hemin, suggesting an important role of TSPO in the hemin activity. Cell viability
assay further conﬁrms the high cytotoxic effects exerted by hemin on Caco-2 cells expressing TSPO compared
to the siRNA-TSPO targeted cells. In addition, hemin was able to decrease signiﬁcantly the TSPO protein density
in a dose dependent manner after 24 h of incubation.
Signiﬁcance: The interaction and the consecutive down regulation of TSPO by hemin played an important role in
the control of Caco-2 cell viability. The presented data suggest that TSPO might contribute to protect cells from
potential toxic compounds such as free tetrapyrroles, candidating this receptor as a survival receptor protein.© 2014 Elsevier Inc. All rights reserved.Introduction
A growing body of experimental evidence suggests that hemin could
play a signiﬁcant role in different human dysfunction such as colorectal
cancer, bowel inﬂammation and neuronal cell injury (Goldstein et al.,
2003). However, the molecular mechanism by which hemin exerts
this effect is still under debate (Goldstein et al., 2003). Hemin is a
lipid-solublemolecule that interacts rapidlywith numerous cell constit-
uents and its toxicity may be mediated by both oxidative and non-oxi-
dative mechanisms (Hebbel and Eaton, 1989). At the high micromolar
concentrations, hemin has been found to be toxic to a variety of cell
types (Balla et al., 1992; Bhoite-Solomon et al., 1993; Braverman et al.,
1995; da Silva et al., 1996). In this perspective, Noguchi et al. (1982)
have reported that a considerable amount of hydrogen peroxide
(H2O2) is produced during heme degradation, catalyzed by the. Pharmacology, University of
a, Italy. Tel.: +39 0592055367;reconstituted heme oxygenase (HO) system. Ferrous irons and H2O2
are able to cleave DNA through Fenton reaction at sequence-speciﬁc
sites often found in telomere repeats (Henle et al., 1999), and therefore
they might play a pivotal role in cell fate. Recently it has been proposed
that heme is able to induce the production of H2O2 by the inducible
heme oxygenase type 1 (HO-1) in colonic epithelial cells (Caco-2),
which participates in DNA damage, cell proliferation, apoptosis, and
the production of inﬂammatory cytokines (Ishikawa et al., 2010). More-
over, the ﬁnding that catalases and zinc-protoporphyrin inhibited the
hyper proliferation in Caco-2 cells supports a key role of HO-1 and oxi-
dative stress in cell damage (Nowis et al., 2008). Interestingly, hemin,
thanks to its chemical conﬁguration, is able to interact with an intracel-
lular receptor mainly localized on the external mitochondrial mem-
brane called 18 kDa translocator protein (TSPO) (Taketani et al.,
1995). Although some cellular functions of TSPO are conserved, such
as cholesterol binding and transport, its biological signiﬁcance seems
to have adapted to serve speciﬁc functions (Batarseha and
Papadopoulos, 2010), such as cell proliferation (Corsi et al., 2008;
Shoukrun et al., 2008; Zeno et al., 2012). Indeed, the knockdown of
the protein resulted in a 60% reduction in the number of C6 glioma
cells in the pre-G1 apoptotic phase, suggesting an anti-apoptotic role
15C. Gemelli et al. / Life Sciences 107 (2014) 14–20of TSPO (Levin et al., 2005). The ﬁnding that speciﬁc TSPO ligands
such as the 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-
isoquinolinecarboxamide (PK 11195) and the 4′-chlorodiazepam
(Ro 5-4864) attenuate apoptosis in human glioblastoma cells
suggests that TSPO activity is intimately related to cell type or tissue
analyzed (Kugler et al., 2008). Nevertheless, the conservation of
TSPO throughout evolution highlights the signiﬁcance of this protein
for proper cellular function and development.
Therefore, there is a substantial possibility that the effect of heme on
cell fatemight be related to an interactionwith TSPO. The present study
was planned to investigate the effect of heme on human colon adeno-
carcinoma Caco-2 cell proliferation through a direct modulation of
TSPO and/or HO-1. For this purpose, we utilized serial treatments with
hemin in association or not with the speciﬁc TSPO ligand PK 11195 or
the speciﬁc HO-1 inhibitor Sn-protoporphyrin IX (Sn-PPIX).
Material and methods
Cell line
Human colon adenocarcinoma Caco-2 cells (RCB0988) from the
Riken Cell Band (Tsukuba, Japan) were maintained in DMEM
supplemented with 10% fetal bovine serum, 100 μg/mL streptomy-
cin, 100 U/mL penicillin, and 1% nonessential amino acids. The cells
were cultured in a humidiﬁed incubator at 37 °C with 95% atmo-
spheric air/5% CO2. Caco-2 cells were used between the 15th and
26th passages. For all experiments, the cells were seeded at a density
of 3 × 104 cells/cm2 in cell culture plates. The cells were carefully
treated to avoid as much light exposure as possible.
Cell treatments
After 24-h growth in the appropriate culture plates, the growth me-
dium was replaced with a medium containing reduced 5% fetal bovine
serum. Hemin, Sn-PPIX and PK 11195 (Sigma, Italy) were prepared on
a stock solution in 1 M sodium hydroxide and/or DMSO and further
diluted in the non-supplemented DMEM. Caco-2 cells were exposed
to different concentrations of hemin (0.1–1mM) for 0–6–24 h in the ab-
sence and presence of various concentrations of PK 11195 (1–50 μM) or
Sn-PPIX (5 μM). Control cells were maintained in no supplemented
DMEM.
Cell viability
Caco-2 cells were plated on 96-well plates (Euroclone, Italy) at a
concentration of 2000 cells/cm2. After exposure to the desired concen-
trations of hemin in the presence or not of PK 11195 and Sn-PPIX,
20 μl MTS (CellTiter 96® Aqueous One Solution Cell Proliferation
Assay, Promega, Italy) was added to each well and incubated for a
period of 2.5 h. Finally, absorption was measured at 492 nm using
a Multiscan microplate reader (Labsystem Multiscan® MCC/340,
Finland).
LDH assay
Hemin was directly added to differentiated cultures to the desired
concentration. At the end of the exposure period (24 h), cell injury
was estimated by examination of cultures under phase-contrastmicros-
copy andwas quantiﬁed bymeasuring lactate dehydrogenase (LDH) re-
lease into the culturemedium following themanufacturer's instructions
(Cytotoxicity Detection kit Roche-Applied-Sciences, Italy) Brieﬂy, 100 μl
sample of the mediumwas removed from each culture and was placed
in a 96-well assay plate. Then 100 μl of the reaction mixture composed
by Diaphorase/NAD+, tetrazolium chloride and sodium lactate was
added to each well. The absorbance of the reaction mixture at 492 nm
was determined using a multiskan plate reader (LabsystemMultiscan®MCC/340, Finland). The LDH signal that was associated with 100% cell
death was determined by lysing cells with 0.2% Triton X-100.
Cell proliferation
Cell proliferation was measured by 5-bromo-20-deoxyuridine
(BrdU) incorporation assay. This assay was performed with a BrdU cell
proliferation ELISA kit (Roche-Applied-Sciences, Italy) according to the
manufacturer's instructions. Brieﬂy, Caco-2 cells were labeled with
BrdU after the treatments and incubated for an additional 2 h. The label-
ing medium was removed, and the cells were dried. Thereafter, cellular
DNA was denaturated by adding a ﬁxative solution for 30 min at room
temperature. After removal of the ﬁxative solution, anti-BrdU antibody
conjugated with a peroxidase solution was added to each well, and the
cells were incubated for 90 min at room temperature. After three
washes with PBS, tetramethylbenzidine solution was added to each
well, and the cells were incubated for 15 min at room temperature.
The reaction was terminated with 1 M H2SO4, and the absorbance at
450 nm (reference wavelength 655 nm) was read using the Multiscan
microplate reader (Labsystem Multiscan® MCC/340, Finland).
Measurement of ROS
ROS were measured using CellROX® Green Reagent as described by
the manufacturer's instructions. Brieﬂy, CellROX® Green Reagent is a
ﬂuorogenic probe designed to reliablymeasure oxidative stress in living
cells. The cell-permeable green dye is non ﬂuorescent while in a re-
duced state and, upon oxidation, exhibits excitation/emission maxima
at 485/520 nm. CellROX® Green Reagent is a DNA dye, and upon
oxidation, it binds to DNA; thus, its signal is localized primarily in the
nucleus and mitochondria. Caco-2 cells were seeded on 96-well plates
at 20 × 103 cells/well and treated with hemin at different concentra-
tions, for the indicated time intervals, and CellROX® Green Reagent
was added at a ﬁnal concentration of 5 μM to the cells and then incubat-
ed for 30min at 37 °C. Subsequently, themediumwas removed, and the
cells were washed three times with PBS. The resulting ﬂuorescence was
measured using a ﬂuorometer (Fluoroskan ascent FL). Menadione
100 μMwas added 30 min before treatment with CellROX® as a refer-
ence ROS inducer drug.
Immunoblotting
The culturemediumwas aspirated, and themonolayer was immedi-
ately lysed in 100 μl of buffer containing 210 mMmannitol, 70 mM su-
crose, 5mMHEPES, 1mMEDTA, 0.1% sodiumdodecyl sulfate (SDS), and
a protease inhibitor cocktail (Sigma, Italy). Protein concentration was
determined by the Bio-Rad Protein Assay kit. Protein samples from
Caco-2 cells treated or not for 24 h with 10 and 200 μM of hemin were
solubilized in Nu-Page sample buffer (141 mM Tris base, 106 mM
Tris–HCl pH 7.4 SDS 2%, 0.51 mM EDTA, 0.22 mM serva blu, 175 mM
phenol red, and 0.05 M DTT) (Invitrogen, Italy), boiled for 5 min and
loaded onto a pre-cast 12% SDS-PAGE. Separated proteins were electro-
phoretically transferred to a nitrocellulose membrane (Invitrogen,
Italy). The membrane was blocked in TBST (20 mM Tris–HCl, 0.5 M
NaCl and 0.05% Tween 20) buffer containing 5% non-fat driedmilk over-
night at 4 °C or 1 h at room temperature and probed with speciﬁc pri-
mary polyclonal antibody anti-TSPO (Anti-TSPO polyclonal antibody
Trevigen, USA), anti-HO-1 (Rabbit polyclonal to heme oxygenase-1,
Abcam, UK) and anti-tubulin (Mouse monoclonal antibody β-tubulina,
Santa Cruz, USA) (1:1000) for 3 h under gentle agitation. Themembrane
was thenwashed 3 times in TBST for 10min each time, incubated for 1 h
with HRP-conjugated anti-rabbit antibody (Santa Cruz, USA) or with
HRP-conjugated anti-mouse antibody (Santa Cruz, USA) and visualized
using chemiluminescence (Amersham, UK). The speciﬁcity of the
band recognized by the anti-TSPO antibody was demonstrated using
pre-adsorbed antibody prepared by incubating the antibody with
Fig. 2. Hemin is toxic at low micromolar concentrations. Cultures (n. 6–8 per condition)
were exposed to the indicated concentrations of hemin for 24 h. LDH values, expressed
as the mean ± SD of three independent experiments, are scaled to those in untreated
cultures exposed continuously to 0.1% Triton X-100, which releases 100% of culture LDH.
The low mean LDH values in the medium of untreated cultures from the same plating
were subtracted from all values. ***P b 0.001 vs. control cells exposed to the culture
medium only. One way ANOVA and Dunnett's as post test.
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as previously described (Corsi et al., 2004).
Gene silencing
TSPO silencing was achieved in Caco-2 colon cancer cells using a
100 nM concentration of a mixture of three pre-designed siRNA
duplexes (Sigma Aldrich, St. Louis, MO, USA; Oligo name: SASI_
Hs01_00054088; SASI_Hs01_00054087; SASI_Hs01_00054085) and
15 μl of Lipofectamine RNAimax reagent (Life Technologies). Two
rounds of “Reverse Transfection”, performed according to the supplied
protocol, were carried out on 0.4 × 106 cells every 24 h and, following
a 48 h period of incubation, a dose of 50 μM of hemin was added for
additional 24 h. Each experiment included a negative control represent-
ed by a non-targeting siRNA synthesized by Sigma-Aldrich in order to
exclude the non-speciﬁc effects of siRNA transfection.
Statistical analysis
All data are presented as the mean ± SD of at least three different
experiments done in quadruplicate. One-way ANOVA analysis of
variance and Dunnett's and Newmann–Keuls' test were performed to
compare differences between the groups, and t-test was performed to
compare two groups, as indicated in the ﬁgures (Graph-Pad 5 Software
Inc, San Diego, CA, USA). P values b0.05 were considered signiﬁcant.
Results
Hemin toxicity at different time points
Fig. 1 summarizes the results on cell viability as measured by MTS
assay at 6 and 24 h. Hemin decreases the cell viability in a dose and
time dependent manner. In particular the effect was greater after 24 h
of incubation, where the inhibition of cell viability was signiﬁcant at
all the concentrations tested, reaching a maximum effect at 500 μM
and 1 mM concentrations (IC50 = 1 mM). After 6 h, the incubation
with hemin resulted in amarked decrease of cell growthwhich reached
signiﬁcant values only at the higher concentrations tested.
Continuous exposure to hemin for 24 h produced cell toxicity, as
determined by LDH release, which increased dramatically between 50
and 200 μM hemin (Fig. 2). Exposure to 10 μM hemin did not produce
any variation of LDH release by Caco-2 cell line.
Effect of hemin on Caco-2 cell proliferation
The cells were treated for 6 to 24 h with various concentrations
of hemin ranging from 0.1 to 200 μM, and cell proliferation wasFig. 1. Effect of hemin Caco-2 cell viability. Cells were treated with various concentrations
(0.01 to 1 mM) of hemin for 6 (grey bars) and 24 h (white bars). Cell viability was
determinedby theMTT assay. The cell viabilitywas directly proportional to theproduction
of formazan, which was measured spectrophotometrically at 492 nm. Values are of three
independent experiments. ***P b 0.001, compared with the untreated control. One-way
ANOVA with Dunnett's as post test.determined by the BrdU incorporation assay. The rationale for the
choice of these concentrations ranges comes from the results obtained
on Caco-2 cell toxicity.
As expected (Fig. 3), the cell proliferation was signiﬁcantly inhibited
in a dose dependent manner, conﬁrming the results obtained on cell
toxicity. After 6 and 24 h of incubation, hemin peaked at 200 μM and
the decrease being 71 and 87% respectively. The IC50 at 6 and 24 h
were 150 and 50 μM respectively.Effect of hemin on heme oxygenase expression
Heme oxygenase expression was assessed at base-line (Ctrl) and
after exposure to hemin at two different concentrations. In these exper-
iments, cultures were exposed to 10 and 200 μM hemin concentration
for 24 h; untreated controls were kept in the same serum-free culture
medium. At the former time point, hemin-exposed cells decrease they
proliferative activity but are still viable in particular at the lower
concentration tested. As shown in Fig. 4a in untreated cultures, HO-1
immunoreactivity was minimal, but after hemin exposure, a signiﬁcant
increase in HO-1 was observed in particular for the 200 μM concentra-
tion treatment (Fig. 4b). However, as shown in Fig. 5, Sn-PPIX (5 μM)
a selective inhibitor of HO-1, which did not alter cyclin D1 activity,
wasunable to reverse or rescue Caco-2 cells after 24h hemin treatments
at all the concentrations tested.Fig. 3. Effect of the concentration of hemin on the proliferation of human colonic epithelial
Caco-2 cells. The cells were treated for 6 (white bars) and 24 h (grey bars) with various
concentrations of hemin (0.1 to 200 μM), and cell proliferation was determined by the
BrdU incorporation assay which was measured at 450 nm. The values are expressed as
the mean ± SD of four independent experiments. ** P b 0.01 and***P b 0.001, compared
with the untreated control. One-way ANOVA with Dunnett's as post test.
Fig. 4. Effect of hemin onHO-1 in human colonic epithelial Caco-2 cells. a): Representative
western blots and b): densitometric analyses of protein levels of HO-1 of Caco-2 cell lysate
after incubation with 10 and 200 μM of hemin for 24 h. Densitometry values were
normalized to the protein loading control, beta-actin. The values are expressed as the
mean ± SD of three independent experiments (n = 6 per group). *** P b 0.001 vs
untreated cells (Ctrl); ## P b 0.01 vs hemin 10 μM, using one-way ANOVA with and
Newmann–Keuls as post test.
Fig. 6. Effects of hemin on intracellular ROS production. Caco-2 cells were treated with
different concentrations of hemin (50–100–200 μM) at 6 h (a) and 12 h (b). ROS
production was assessed by CellROX® green reagent assay and expressed as arbitrary
units (A.U.). The values are expressed as the mean ± SD of three independent
experiments. 100 μM of Menadione (Men) was used as positive control. The values are
expressed as the mean ± SD of three independent experiments. * P b 0.05, **P b 0.01
and *** P b 0.001 vs untreated cells (Ctrl) using one-way ANOVA with Dunnett's as post
test.
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We focalized our attention on the ability of hemin to induce of ROS
in nuclei, whichmight generate DNA damage, using a speciﬁc CellROX®
green reagent. Caco-2 cells were treated with different concentrations
of hemin for 6 (Fig. 6a) and 12 h (Fig. 6b). After 6 h of incubation
time, hemin signiﬁcantly induced ROS production only at 10 μM con-
centration whereas at 50 and 100 μMwas unable to modulate the ROS
levels. Interestingly, after 12 h of incubation time, hemin signiﬁcantly
decreased the ROS production at all the concentrations tested.Fig. 5. Effects of SnPPIX on hemin-antiproliferative activity in human colonic
epithelial Caco-2 cells. The cells were treated for 24 h with various concentrations of
hemin (50–100–200 μM) alone or in combination with 5 μM of SnPPIX and the cell
proliferation was measured by BrdU assay. The values are expressed as the mean ± SD
of three independent experiments.Interaction of hemin with TSPO
Since the hemin is able to bind TSPOwith relatively high afﬁnity, we
analyzed the ability of the speciﬁc TSPO ligand PK 11195 to interfere
with hemin antiproliferative activity. Fig. 7a shows the effect of PK
11195 (1 μM) on the hemin-antiproliferative activity on Caco-2 cells.
The speciﬁc TSPO ligand was able to signiﬁcantly reduce the inhibition
of cell proliferation elicited by hemin at all the concentrations tested.
However PK 11195 was unable to restore the values to the level of
control. We therefore examined the effect of increasing concentration
of PK 11195 on 50 μM hemin antiproliferative activity. As clearly
shown in Fig. 7b, although PK 11195 counteracts signiﬁcantly the effect
of hemin, its effect was not in a dose dependent manner. We then
evaluate the potential ability of hemin to modulate the amount of
TSPO protein. We analyzed the TSPO protein density in Caco-2
cells after 24 h incubation with hemin at different concentrations. As
shown in Fig. 8a the pharmacological treatments of hemin at 10 and
200 μM had different effects on the relative amount of TSPO detected
by immunoblotting. Compared with control cells, both treatments
down-regulated TSPO protein levels; in particular, 200 μM of hemin
caused about a 55% reduction in detectable TSPO (Fig. 8b).
Fig. 7. Effects of PK11195 on hemin- antiproliferative activity in human colonic
epithelial Caco-2 cells. a): The cells were treated for 24 h with various concentrations of
hemin (50–100–200 μM) alone or in combination with 1 μM of PK11195 and the cell
proliferation measured by BrdU assay. The values are expressed as the mean ± SD of
three independent experiments. * P b 0.05 vs hemin 50 μM alone and ** P b 0.01 vs
hemin 100 and 200 μM alone t-test. b): PK 11195 dose-dependent inhibition of hemin
antiproliferative activity. The cells were treated for 24 h with 50 μM of hemin in the
presence or not of various concentrations of PK 11195 (1–10–50 μM). The values are
expressed as the mean ± SD of three independent experiments. ** P b 0.01 vs 200 μM
hemin alone using one-way ANOVA with Dunnett's as post test.
Fig. 8. Effect of hemin on TSPO protein in human colonic epithelial Caco-2 cells. a): Repre-
sentative western blots and b): densitometric analyses of protein levels of TSPO of Caco-2
cell lysate after incubation with 10 and 200 μM of hemin for 24 h. Densitometry values
were normalized to the protein loading control, beta-actin. The values are expressed
as the mean ± SD of three independent experiments (n= 6 per group). ** P b 0.01 and
*** P b 0.001 vs untreated cells (Ctrl); ### P b 0.001 vs hemin 10 μM, using one-way
ANOVA with Newmann–Keuls as post test.
Fig. 9. Evaluation of Caco2 cell viability under TSPO silencing condition. a): Western blot
analysis of TSPO protein expression upon transient siRNA transfection. The analyzed
protein and samples are respectively indicated on the top and on the left of the panel.
Expression of beta-actin was also evaluated to normalize the amount of protein extract
loaded in the various lanes. b): MTS assay was carried out on siRNA transfected cells and
upon hemin treatment. The histogram reports the cell viability data achieved in Caco2
cells transfected with a control or with TSPO-targeting siRNA and treated with a 50 μM
of hemin for 24 h. Untreated samples were also reported. The data are indicated as
mean ± SD of three independent experiments. * P b 0.05 using paired t-test.
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In order to evaluate the role of TSPO in the maintenance of cell via-
bility, we performed TSPO silencing experiments in Caco-2 cells. TSPO
inhibition was obtained according to “Reverse Trasfection” protocol
supplied by Lipofectamine RNAimax. After 48 h of incubation, the cells
were treated or not with 50 μM concentration of Hemin for 24 h and
cell viability was determined. TSPO down-regulation was ﬁrstly
assessed byWestern blot analysis. The result, reported in Fig. 9a, clearly
demonstrated the strong inhibition of TSPO protein compared to Caco-2
cells treated with a non-targeting siRNA, referred as a control. Subse-
quently, the data achieved byMTS assay, highlighted several interesting
ﬁndings (Fig. 9b). These results ﬁrstly revealed a strong reduction of cell
viability in the absence of TSPO expression. In addition, in the hemin
treated samples, MTS assay further conﬁrms the high cytotoxic effects
exerted by this molecule on Caco-2 cells expressing TSPO as compared
to the siRNA-TSPO targeted cells (Fig. 9b). Indeed, in the presence of
low levels of TSPO transcript, Caco-2 cells were able to counteract the
toxicity exerted by hemin, partially restoring cell proliferation and
viability.
Discussion
Epidemiological studies have shown that Western-style diet (high
meat, high fat, low ﬁber) is a high risk factor for colon cancer. Incidence
increases in countries with a high meat consumption (Armstrong and
Doll, 1975). It has been shown that hemoglobin is genotoxic in human
colon cells, and that this is associated with free radical mechanisms
and with cytotoxicity, especially for hemin (Glei et al., 2006). However,
several lines of evidence indicate that hemin possesses both the
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et al., 2010; Noda et al., 2001) This apparent discordance might rely
on the concentration of hemin end/or the intracellular ROS production
through heme oxygenase-1 induction. In this context, our data indicates
that hemin induced cell toxicity in Caco-2 cell line in a dose and timede-
pendent manner, reaching a maximum effect after 24 h of incubation.
Indeed, the inhibition of cell proliferation elicited by hemin did not
merge the LDH production at the same concentrations and times tested.
This evidence suggests a possible different molecular mechanism
involving the regulation of cell viability. It has been reported that the
toxic effect of hemin is mostly due to the production of ROS (Ishikawa
et al., 2010; Noda et al., 2001) through HO-1 induction. However, in
this context, the role of HO-1 is still controversial. Several researchers
on neuronal cells showed that iron release from hemin after HO-1
activity was responsible of the cell toxicity (Goldstein et al., 2003;
Dwyer et al., 1998; Huang et al., 2002). However, Regan et al. (2000)
previously observed that HO-1 induction was protective in cultured
astrocytes exposed to hemoglobin (Regan et al., 2000). A beneﬁcial
effect of HO-1 has also been observed by Doré and Snyder (1999) in
hippocampal neurons exposed to hydrogen peroxide and in systems
of non-neural origin (Vile et al., 1994; Abraham et al., 1995; Dennery
et al., 1997; Ishikawa et al., 2010). Our result on ROS generations indi-
cates that hemin increased ROS production only at the low concentra-
tion and at the shorter incubation time. The evidence that high
concentrations of hemin failed to induce the production ROS is probably
due to the induction of HO-1, which mediated antioxidant activity.
However, our data showed that despite the induction of HO-1 produced
by hemin, the speciﬁc inhibition of HO-1 with Sn-PPIX was unable to
restore Caco-2 cell proliferation. One explanation could be that the
beneﬁcial effect of converting hemin to an antioxidant (biliverdin)
might be overcome by other molecular mechanisms able to inhibit cell
viability of Caco-2 cells. Another explanation might be addressed to
the type of assay used. In order to verify the presence of ROS in the
nuclei, and their potential genotoxicity, we used a speciﬁc assay able
to detect ROS in the nucleus andmitochondria, but not in the cytoplasm,
probably underestimating the total production of ROS elicited by hemin.
However, Menadione, used, as positive control of ROS generator, was
able to signiﬁcantly increase the levels of ROS in the nuclei and/ormito-
chondria, suggesting that most likely the induction of HO-1 has played
an important role on the lack of hemin pro-oxidant activity at the
highest concentrations tested. The ﬁnding that hemin is able to bind
the intracellular mitochondrial receptor TSPO, with nanomolar afﬁnity,
strongly suggests a possible involvement of this protein in the hemin
antiproliferative and/or cytotoxic effect. TSPO is involved in a number
of cellular functions such as cholesterol transport, cell proliferation
and apoptosis (Papadopoulos et al., 2006). Although the pharmacologi-
cal modulation of TSPO has been extensively described, and it is known
the ability of hemin to bind TSPO (Taketani et al., 1995), there are no ev-
idence on the modulation of cell growth after the binding of hemin to
TSPO. We then evaluated the antiproliferative effect of hemin in the
presence or not of the speciﬁc TSPO ligand PK 11195, which per se did
not alter Caco-2 cell proliferation (data not shown). The ability of PK
11195 to inhibit partially the hemin effect suggests an involvement of
TSPO on hemin activity and a possible modulation of the receptor by
this molecule. In particular, our data suggest that the binding of hemin
to TSPO elicits a cytotoxic effect rather than an inhibition of cell prolifer-
ation, which might be a logical unspeciﬁc consequence of cytotoxicity.
The latest assumption is sustained also by the transient siRNA targeting
TSPO transfection data, where the cytotoxic effect of hemin in Caco-2
cells expressing TSPO was higher than the one observed in the siRNA-
TSPO directed cells. It must be remarked that the transient siRNA direct-
ed against TSPO transfection alone resulted in a signiﬁcant decrease of
Caco-2 cell viability compared to the control, indicating that TSPO is a
crucial protein for the cell viability. Indeed, it is known that its functional
inactivation induces an early embryonic-lethal phenotype in mouse
(Papadopoulos et al., 1997). In addition, it has been demonstrated thatstable overexpression of TSPO, in mammary epithelial MCF10A acini,
drives proliferation and provides partial resistance to luminal apoptosis
(Wu and Gallo, 2013). The discrepancy between our results and those
obtained on HT 29 colon cancer cell line, where TSPO knock down
produced a decrease of apoptosis and increase of cell proliferation
(Shoukrun et al., 2008), should be addressed to the different cell line
adopted in the experiments. Although Caco-2 cells are derived from
a human colon adenocarcinoma, they retain the ability to polarize
and form a transporting epithelial monolayer in cell culture, which
has many characteristics of polarized intestinal enterocytes in situ
(Grasset et al., 1985). In such cell system, the TSPO density is far
less than in HT 29, and this difference might be of relevance in the
modulation of biological processes involving cell proliferation and/or
cytotoxicity.
Moreover the results obtained by immunoblotting on TSPO protein
clearly showed a down regulation of the receptor protein. Taking into
account that a knock down of TSPO is related to an increase of cell
death, and that the receptor is fundamental for the cell growth (Levin
et al., 2005), we could surmise that the inhibition of Caco-2 cell viability
might be due, at least in part, to the hemin-related TSPO degradation. In
this context, recently, in Arabidopsis thaliana, it has been shown that the
interaction of heme with the tryptophan-rich sensory protein (At-
TSPO), a related membrane protein belonging to protein/peripheral-
type benzodiazepine receptor protein family, produced a down
regulation of the receptor, suggesting a potential role of At-TSPO as a
scavengers of free tetrapyroles (Vanhee et al., 2011). In addition, it has
been reported that the heme binding regulates At-TSPO degradation,
through an active autophagy pathway, suggesting that the physiological
consequence of active At-TSPO down regulation may be heme scaveng-
ing (Vanhee et al., 2011). Our results strongly support this evidence, and
reinforce the idea that TSPO might act as a scavenger of porphyrin-
based compounds also in eukaryotic model such as Caco-2 cell line.
Conclusion
Finally, our data showed a new mechanism by which hemin modu-
lates cell viability and proliferation on Caco-2 cell line. The interaction
and the consecutive down regulation of TSPO by hemin might play an
important role in the control of cell viability. In addition, the data
presented suggest that TSPO might contribute to protecting cells from
potential toxic compounds such as free tetrapyrroles, candidating the
TSPO as a survival receptor protein.
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